RECURRENT GENITAL HERPES SIMPLEX TYPE 2
Clinical trials for RECURRENT GENITAL HERPES SIMPLEX TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GENITAL HERPES SIMPLEX TYPE 2 trials appear
Sign up with your email to follow new studies for RECURRENT GENITAL HERPES SIMPLEX TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New herpes drug enters early human testing
Disease control CompletedThis early-stage study tested a new drug called ABI-5366 in 115 people to see if it is safe and how the body processes it. Part A involved healthy volunteers receiving a single dose, while Part B included people with recurrent genital herpes who received multiple doses. The goal …
Matched conditions: RECURRENT GENITAL HERPES SIMPLEX TYPE 2
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill aims to tame genital herpes outbreaks
Disease control CompletedThis early study tests an experimental drug called ABI-1179 in healthy volunteers and people with recurrent genital herpes caused by HSV-2. The main goal is to check safety and how the body processes the drug. Researchers will give single or multiple doses and monitor for side ef…
Matched conditions: RECURRENT GENITAL HERPES SIMPLEX TYPE 2
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC